HighTower Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-500
Closed -$1.39K 3871
2025
Q2
$1.39K Buy
+500
New +$136K ﹤0.01% 3720
2023
Q2
Sell
-100
Closed -$2.94K 3475
2023
Q1
$2.94K Buy
+100
New +$18.1K ﹤0.01% 3268
2022
Q3
Sell
-100
Closed -$2K 3186
2022
Q2
$2K Buy
+100
New +$21.2K ﹤0.01% 3158
2018
Q3
Sell
-10,500
Closed -$11K 2308
2018
Q2
$11K Buy
+10,500
New +$1.71M ﹤0.01% 2135
2013
Q4
Sell
-100,500
Closed -$97K 1552
2013
Q3
$97K Buy
100,500
+25,500
+34% +$1.88M ﹤0.01% 1217
2013
Q2
$484K Buy
+75,000
New +$4.92M 0.01% 814

Other funds holding CME

HighTower Advisors's CME Position: Q2 2026 in Review

HighTower Advisors reduced its CME Group (CME) stake by 20% in Q2 2026, selling an estimated $20.5M and leaving 300,011 shares worth $66.3M. The position accounts for 0.06% of the portfolio, ranked #301.

HighTower Advisors first reported a position in CME in Q3 2013 and has held it in 51 quarters since. The position peaked at $111M in Q1 2026. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • HighTower Advisors held 300,011 shares of CME Group worth $66.3M as of Q2 2026.
  • HighTower Advisors sold 74,167 CME Group shares in Q2 2026, an estimated $20.5M.
  • CME Group made up 0.06% of HighTower Advisors's portfolio in Q2 2026, its #301 holding.
  • HighTower Advisors first reported a position in CME Group in Q3 2013 and has held it in 51 quarters since.
  • HighTower Advisors's CME Group position peaked at $111M in Q1 2026.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.